Company Description
Innogenetics NV is an international biotechnological company that develops and markets diagnostic products to improve therapy management and patient health.
Innogenetics develops and markets a wide range of diagnostic assays with a focus on molecular Diagnostics and multiparameter testing. Its products are sold in over 90 countries through its 6 subsidiaries and a large number of distributors. In 2007, Diagnostics sales totalled EUR 47.0 million, more than 95% of which were achieved outside Belgium.
Founded in 1985, Innogenetics is listed on Euronext Brussels [Ticker: INNX].